A growing number of evidence has shown that ChREBP is involved in the pathogenesis of hepatic steatosis and IR, but the current records are still controversial about the roles of hepatic ChREBP in IR development (reviewed in [76,77]). This evidence concerns the gene MLXIPL and fatty liver disease.